Clinical Trial

GKL-006Allo Injection in Patients With Advanced Solid Tumors

Name: GKL-006Allo Injection in Patients With Advanced Solid Tumors — clinical trial record (NCT07704515)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity, and preliminary anti-tumor activity of GKL-006Allo Injection in participants with advanced solid tumors.

Trial Details

NCT Number	NCT07704515
Lead Sponsor	Beijing Gene Key Life Technology Co., Ltd
Conditions	Solid Tumor Malignancies
Enrollment	27 participants
Start Date	2026-08-30
Primary Completion	2028-09-30 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-15